Effects of the orally active non-peptide bradykinin B2 receptor antagonist, FR173657, on plasma extravasation in guinea pig airways.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  European Journal of Pharmacology

• Publication date

  1999-02-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0014-2999(98)00964-9PMID 10079013
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impairment of bronchoprotection by nitric oxide in severe asthma.

  1997cited by this paper
• The capsaicin receptor: a heat-activated ion channel in the pain pathway

  1997cited by this paper
• The control of microvascular permeability and blood pressure by neutral endopeptidase

  1997cited by this paper
• Effects of the non‐peptide B2 antagonist FR173657 on kinin‐induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release

  1997cited by this paper
• The human mast cell.

  1997cited by this paper
• The identification of an orally active, nonpeptide bradykinin B2 receptor antagonist, FR173657

  1997cited by this paper
• Tachykinin and kinin receptor antagonists: therapeutic perspectives in allergic airway disease.

  1996cited by this paper
• Randomised double-blind placebo-controlled study of the effect of inhibition of nitric oxide synthesis in bradykinin-induced asthma.

  1996cited by this paper
• Effect of MDL 105,212, a nonpeptide NK-1/NK-2 receptor antagonist in an allergic guinea pig model.

  1996cited by this paper
• Corticotropin-releasing factor inhibits antigen-induced plasma extravasation in airways.

  1995cited by this paper
• Direct observation of substance P-induced internalization of neurokinin 1 (NK1) receptors at sites of inflammation.

  1994cited by this paper
• Expression cloning of a human B1 bradykinin receptor.

  1994cited by this paper
• Role of kinins in the vascular extravasation evoked by antigen and mediated by tachykinins in guinea pig trachea.

  1993cited by this paper
• Role of peptidases and NK1 receptors in vascular extravasation induced by bradykinin in rat nasal mucosa.

  1993cited by this paper
• Design of potent non-peptide competitive antagonists of the human bradykinin B2 receptor.

  1993cited by this paper
• A new NK1 receptor antagonist (CP-99,994) prevents the increase in tracheal vascular permeability produced by hypertonic saline.

  1993cited by this paper
• Allergen-induced biphasic plasma exudation responses in guinea pig large airways.

  1993cited by this paper
• Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor.

  1992cited by this paper
• Bioregulation of kinins: kallikreins, kininogens, and kininases.

  1992cited by this paper
• Elevation of tissue kallikrein and kinin in the airways of asthmatic subjects after endobronchial allergen challenge.

  1992cited by this paper
• Hoe 140 a new potent and long acting bradykinin‐antagonist: in vitro studies

  1991cited by this paper
• Hoe 140 a new potent and long acting bradykinin‐antagonist: in vivo studies

  1991cited by this paper
• Release of multiple tachykinins from capsaicin-sensitive sensory nerves in the lung by bradykinin, histamine, dimethylphenyl piperazinium, and vagal nerve stimulation.

  1988cited by this paper
• Development of a prolonged eosinophil-rich inflammatory leukocyte infiltration in the guinea-pig asthmatic response to ovalbumin inhalation.

  1988cited by this paper
• Simultaneous release by bradykinin of substance P‐and calcitonin gene‐related peptide immunoreactivities from capsaicin‐sensitive structures in guinea‐pig heart

  1988cited by this paper
• Bradykinin-induced bronchoconstriction in humans. Mode of action.

  1987cited by this paper
• Capsaicin-induced desensitization of airway mucosa to cigarette smoke, mechanical and chemical irritants

  1983cited by this paper
• Pharmacology of bradykinin and related kinins.

  1980cited by this paper

• Inundation of asthma target research: Untangling asthma riddles.

  2016cites this paper
• The Cannabinoid Receptor Agonist WIN 55,212-2 Inhibits Antigen-Induced Plasma Extravasation in Guinea Pig Airways

  2010cites this paper
• Peptide and non-peptide bradykinin receptor antagonists: role in allergic airway disease.

  2006cites this paper
• Effects of a selective bradykinin B1 receptor antagonist on increased plasma extravasation in streptozotocin-induced diabetic rats: distinct vasculopathic profile of major key organs.

  2005cites this paper
• Anti-allergic effects of natural tetranortriterpenoids isolated from Carapa guianensis Aublet on allergen-induced vascular permeability and hyperalgesia

  2005cites this paper
• Effect of FK3657, a non-peptide bradykinin B2 receptor antagonist, on allergic airway disease models.

  2003cites this paper
• Effects of a bradykinin B(2) receptor antagonist, FR173657, on pulmonary ischemia-reperfusion injury in dogs.

  2002cites this paper
• Species differences in bradykinin receptor-mediated responses of the airways.

  2002cites this paper
• Peptide-binding G protein-coupled receptors: new opportunities for drug design.

  2001cites this paper
• Kinin receptors and their antagonists as novel therapeutic agents.

  2001cites this paper
• Kinin Receptor Antagonists

  2001cites this paper
• Characterization of bradykinin B2 receptor antagonists in human and rat urinary bladder

  2000cites this paper
• Kinins in pain and inflammation

  2000cites this paper
• Characterization of bradykinin B(2) receptor antagonists in human and rat urinary bladder.

  2000cites this paper